Swiss National Bank Has $2.12 Million Holdings in U.S. Physical Therapy, Inc. $USPH

Swiss National Bank cut its stake in U.S. Physical Therapy, Inc. (NYSE:USPH) by 1.0% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 29,300 shares of the company’s stock after selling 300 shares during the period. Swiss National Bank owned about 0.19% of U.S. Physical Therapy worth $2,120,000 at the end of the most recent reporting period.

Other hedge funds have also modified their holdings of the company. Mitsubishi UFJ Asset Management Co. Ltd. raised its holdings in shares of U.S. Physical Therapy by 952.4% in the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 442 shares of the company’s stock worth $32,000 after buying an additional 400 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. acquired a new position in shares of U.S. Physical Therapy in the 4th quarter worth approximately $39,000. Fifth Third Bancorp raised its holdings in shares of U.S. Physical Therapy by 34.6% in the 1st quarter. Fifth Third Bancorp now owns 1,030 shares of the company’s stock worth $75,000 after buying an additional 265 shares in the last quarter. Lazard Asset Management LLC acquired a new position in shares of U.S. Physical Therapy in the 4th quarter worth approximately $84,000. Finally, Aquatic Capital Management LLC raised its holdings in shares of U.S. Physical Therapy by 18.0% in the 4th quarter. Aquatic Capital Management LLC now owns 1,298 shares of the company’s stock worth $115,000 after buying an additional 198 shares in the last quarter.

U.S. Physical Therapy Stock Up 3.6%

Shares of USPH opened at $87.5170 on Friday. The firm has a market capitalization of $1.33 billion, a price-to-earnings ratio of 38.22, a PEG ratio of 4.47 and a beta of 1.45. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.18 and a current ratio of 1.18. The business’s fifty day moving average price is $78.26 and its two-hundred day moving average price is $76.83. U.S. Physical Therapy, Inc. has a 52 week low of $62.77 and a 52 week high of $101.19.

U.S. Physical Therapy (NYSE:USPH) last announced its quarterly earnings data on Wednesday, August 6th. The company reported $0.81 EPS for the quarter, beating analysts’ consensus estimates of $0.71 by $0.10. The firm had revenue of $197.34 million for the quarter, compared to analyst estimates of $190.24 million. U.S. Physical Therapy had a return on equity of 8.78% and a net margin of 5.05%.The business’s quarterly revenue was up 18.0% compared to the same quarter last year. During the same period last year, the company earned $0.73 EPS. On average, analysts predict that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current year.

U.S. Physical Therapy Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, September 12th. Shareholders of record on Friday, August 22nd will be given a $0.45 dividend. This represents a $1.80 dividend on an annualized basis and a yield of 2.1%. The ex-dividend date is Friday, August 22nd. U.S. Physical Therapy’s dividend payout ratio (DPR) is presently 78.60%.

Analyst Ratings Changes

A number of research firms recently commented on USPH. Zacks Research upgraded U.S. Physical Therapy to a “hold” rating in a research report on Friday, August 8th. Wall Street Zen upgraded U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research report on Thursday, May 8th. Finally, Barrington Research increased their price target on U.S. Physical Therapy from $98.00 to $103.00 and gave the stock an “outperform” rating in a research report on Friday, August 8th. One analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $110.25.

Insiders Place Their Bets

In other U.S. Physical Therapy news, COO Graham D. Reeve sold 1,792 shares of the stock in a transaction on Monday, August 11th. The stock was sold at an average price of $86.57, for a total value of $155,133.44. Following the transaction, the chief operating officer directly owned 22,246 shares in the company, valued at approximately $1,925,836.22. This trade represents a 7.45% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Nancy Ham sold 400 shares of the stock in a transaction on Thursday, June 12th. The shares were sold at an average price of $78.01, for a total value of $31,204.00. Following the completion of the transaction, the director directly owned 2,594 shares in the company, valued at approximately $202,357.94. This trade represents a 13.36% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 2,955 shares of company stock worth $251,170 over the last quarter. Corporate insiders own 2.00% of the company’s stock.

U.S. Physical Therapy Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.